These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29035454)

  • 1. The Relationship Between MDM2 T309G Polymorphism and Leukemia in the Chinese Population: Evidence from a Meta-Analysis.
    Zhao D; Liu T
    Clin Lab; 2017 Oct; 63(10):1639-1645. PubMed ID: 29035454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
    Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
    Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
    Chen B; Xiong MM; Meng XL
    Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
    Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
    Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z; Zhu X; Teng Y
    Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.
    Shen W; Hu P; Cao JQ; Liu XX; Shao JH
    J Int Med Res; 2014 Oct; 42(5):1065-76. PubMed ID: 25070969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis.
    Yin L; Shen G; Zhu B
    Thorac Cancer; 2020 Mar; 11(3):672-678. PubMed ID: 31970867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.
    Pan X; Li Y; Feng J; Wang X; Hao B; Shi R; Zhang G
    BMC Cancer; 2013 Mar; 13():126. PubMed ID: 23506213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 SNP309 variation increases cervical cancer risk among Asians.
    Zhuo X; Ren J; Li D; Wu Y; Zhou Q
    Tumour Biol; 2014 Jun; 35(6):5331-7. PubMed ID: 24532430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
    Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis.
    He X; Chen P; Yang K; Liu B; Zhang Y; Wang F; Guo Z; Liu X; Lou J; Chen H
    Acta Haematol; 2015; 133(4):365-371. PubMed ID: 25790771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients.
    Cho YG; Choi BJ; Song JH; Kim CJ; Cao Z; Nam SW; Lee JY; Park WS
    Neoplasma; 2008; 55(3):256-60. PubMed ID: 18348658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.
    Yadav P; Masroor M; Tanwer K; Mir R; Javid J; Ahmad I; Zuberi M; Kaza RC; Jain SK; Khurana N; Ray PC; Saxena A
    Clin Transl Oncol; 2016 Jul; 18(7):728-34. PubMed ID: 26553387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.
    Chen B; Cao L; Hu KW; Zhang JW; Meng XL; Xiong MM
    Tumour Biol; 2014 Apr; 35(4):3431-8. PubMed ID: 24338709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.
    Cai X; Yang M
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):555-61. PubMed ID: 22205265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.